• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探究毒蕈碱受体变构调节剂在其他G蛋白偶联受体上的选择性。

Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors.

作者信息

Pfaffendorf M, Batink H D, Tränkle C, Mohr K, van Zwieten P A

机构信息

Department of Pharmacotherapy, Academic Medical Center, University of Amsterdam, The Netherlands.

出版信息

J Auton Pharmacol. 2000 Feb;20(1):55-62. doi: 10.1046/j.1365-2680.2000.00163.x.

DOI:10.1046/j.1365-2680.2000.00163.x
PMID:11048962
Abstract
  1. The aim of the present investigation was to analyse whether three prototype allosteric modulators of ligand binding to muscarinic receptors, i.e. alcuronium, gallamine, and the alkane-bis-ammonium compound W84 (hexane-1,6-bis[dimethyl-3'-phthalimidopropylammonium bromide]), may have allosteric effects on radioligand-binding characteristics at other G-protein-coupled receptors, such as cerebral A1 adenosine receptors (Gi-coupled), cardiac left ventricular alpha1-adrenoceptors (Gq), and beta-adrenoceptors (Gs). 2. The modulators were applied at concentrations known to be high with regard to the allosteric delay of the dissociation of the antagonist [3H]-N-methylscopolamine (NMS) from muscarinic M2-receptors: 30 micromol l(-1) W84, 30 micromol l(-1) alcuronium, 1000 micromol l(-1) gallamine. As radioligands, we used the adenosine A1-receptor ligand [3H]-cyclopentyl-dipropylxanthine (CPX), the alpha1-adrenoceptor ligand [3H]-prazosin (PRAZ), and the beta-adrenoceptor ligand (-)-[125I]-iodocyanopindolol (ICYP). Allosteric actions on ligand dissociation and the equilibrium binding were measured in the membrane fractions of rat whole forebrain (CPX) and of rat cardiac left ventricle (PRAZ, ICYP, NMS), respectively. 3. CPX and PRAZ showed a monophasic dissociation with half-lives of 5.88+/-0.15 and 12.27+/-0.46 min, respectively. In the case of CPX, neither the binding at equilibrium nor the dissociation characteristics were influenced by the allosteric agents. With PRAZ, the binding at equilibrium remained almost unaltered in the presence of W84, whereas it was reduced to 36+/-2% of the control value with alcuronium and to 42+/-2% with gallamine. The dissociation of PRAZ was not affected by W84, whereas it was moderately accelerated by alcuronium and gallamine. In the case of ICYP, the binding at equilibrium was not affected by the allosteric modulators. The dissociation of ICYP was slow, and after 3 h, more than 50% of the radioligand was still bound, so that a reliable half-life could not be calculated. ICYP dissociation was not affected by W84. In the presence of alcuronium and gallamine, the dissociation curve of ICYP revealed an initial drop from the starting level, followed by the major phase of dissociation being parallel to the control curve. 4. In summary, the allosteric action of the applied agents is not a common feature of G-protein-coupled receptors and appears to be specific for muscarinic receptors.
摘要
  1. 本研究的目的是分析三种配体与毒蕈碱受体结合的原型变构调节剂,即阿库氯铵、加拉明和烷烃双铵化合物W84(己烷-1,6-双[二甲基-3'-邻苯二甲酰亚胺基丙基溴化铵]),是否可能对其他G蛋白偶联受体的放射性配体结合特性产生变构效应,如脑A1腺苷受体(Gi偶联)、心脏左心室α1肾上腺素能受体(Gq)和β肾上腺素能受体(Gs)。2. 这些调节剂的应用浓度已知对于拮抗剂[3H]-N-甲基东莨菪碱(NMS)从毒蕈碱M2受体解离的变构延迟而言较高:30 μmol/L W84、30 μmol/L阿库氯铵、1000 μmol/L加拉明。作为放射性配体,我们使用了腺苷A1受体配体[3H]-环戊基二丙基黄嘌呤(CPX)、α1肾上腺素能受体配体[3H]-哌唑嗪(PRAZ)和β肾上腺素能受体配体(-)-[125I]-碘氰吲哚洛尔(ICYP)。分别在大鼠全脑(CPX)和大鼠心脏左心室(PRAZ、ICYP、NMS)的膜部分测量了对配体解离和平衡结合的变构作用。3. CPX和PRAZ表现出单相解离,半衰期分别为5.88±0.15分钟和12.27±0.46分钟。就CPX而言,平衡结合和解离特性均未受变构剂影响。对于PRAZ,在W84存在下平衡结合几乎未改变,而在阿库氯铵存在下降至对照值的36±2%,在加拉明存在下降至42±2%。PRAZ的解离不受W84影响,而阿库氯铵和加拉明使其适度加速。对于ICYP,平衡结合不受变构调节剂影响。ICYP的解离缓慢,3小时后仍有超过50%的放射性配体结合,因此无法计算出可靠的半衰期。ICYP的解离不受W84影响。在阿库氯铵和加拉明存在下,ICYP的解离曲线显示从起始水平开始有一个初始下降,随后解离的主要阶段与对照曲线平行。4. 总之,所应用药物的变构作用并非G蛋白偶联受体的共同特征,似乎对毒蕈碱受体具有特异性。

相似文献

1
Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors.探究毒蕈碱受体变构调节剂在其他G蛋白偶联受体上的选择性。
J Auton Pharmacol. 2000 Feb;20(1):55-62. doi: 10.1046/j.1365-2680.2000.00163.x.
2
Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.在系统发育上密切相关的组胺H1受体中测试毒蕈碱受体变构调节剂的特异性。
Naunyn Schmiedebergs Arch Pharmacol. 2000 Feb;361(2):107-12. doi: 10.1007/s002109900176.
3
Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.鉴定毒蕈碱型乙酰胆碱M2受体共同变构位点的[3H]配体。
Mol Pharmacol. 1998 Jul;54(1):139-45. doi: 10.1124/mol.54.1.139.
4
Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.毒蕈碱M2受体阳离子变构调节剂的不同作用模式。
Mol Pharmacol. 1997 Apr;51(4):674-82. doi: 10.1124/mol.51.4.674.
5
Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.从缓冲液依赖性效价变化推导的与游离型及[3H]N-甲基东莨菪碱占据型毒蕈碱M2受体的变构相互作用模式
Naunyn Schmiedebergs Arch Pharmacol. 2000 Dec;362(6):512-9. doi: 10.1007/s002100000316.
6
Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity.毒蕈碱变构调节:加拉明的M2/M3亚型选择性与G蛋白偶联特异性无关。
Naunyn Schmiedebergs Arch Pharmacol. 2001 Aug;364(2):172-8. doi: 10.1007/s002100100441.
7
Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.毒蕈碱M(3)受体外环突变诱导的N-甲基东莨菪碱与变构调节剂阿库氯铵和加拉明之间协同性的变化
Mol Pharmacol. 2001 Oct;60(4):761-7.
8
M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.选择性拮抗剂AF-DX 384与M2受体的结合:共同变构位点的可能参与
Mol Pharmacol. 1998 Feb;53(2):304-12. doi: 10.1124/mol.53.2.304.
9
Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.M2 型乙酰胆碱受体中的变构位点:正构激动剂而非拮抗剂结合后发生重大构象变化的证据。
Naunyn Schmiedebergs Arch Pharmacol. 2006 Jan;372(4):267-76. doi: 10.1007/s00210-005-0023-4. Epub 2005 Dec 16.
10
Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors.使用放射性变构剂来测试加拉明与毒蕈碱型乙酰胆碱M(2)受体变构位点结合的协同模型预测。
Mol Pharmacol. 1999 Nov;56(5):962-5. doi: 10.1124/mol.56.5.962.